Abstract
Hereditary hearing impairment (HHI) is a heterogeneous class of disorders showing various patterns of inheritance and involving a multitude of different genes. Neurosensory hearing impairment is one of the most common human sensory disorders affecting one in 1000 children with at least 60% of cases being inherited. The mode of inheritance of non-syndromic hearing disorders can be assigned to autosomal dominant (10-15%), autosomal recessive (70%), X-linked (1-3%) and mitochondrial forms (6-37% out of all cases). Syndromal hearing defects are categorized according to the underlying defects and contain more than 700 syndromes. In daily practice, non-syndromic hearing impairment (NSHL) is predominant and accounts for up to 70% of all inherited sensorineural hearing defects. Although our knowledge of genes being involved in the development of HI accumulated during the past five years, little is known about the molecular basis of normal auditory function. To date, 24 genes for non syndromic HI and an even larger number of genes for syndromic HI have been identified. These genes play important roles for the normal inner ear: in the development, structure, ion exchange and further physiological function. This review presents a summary of known genes and new candidates, their possible role and the current state of knowledge in genetics of hereditary hearing impairment, all of them possibly expected to allow for new concepts in therapy.
Keywords: hereditary hearing impairment (hhi), non-syndromic, syndromic, development, ion exchange, structure, inner ear physiologogy
Current Genomics
Title: Genes Involved in Hereditary Hearing Impairment
Volume: 4 Issue: 5
Author(s): B. Haack, M. Pfister, N. Blin and S. Kupka
Affiliation:
Keywords: hereditary hearing impairment (hhi), non-syndromic, syndromic, development, ion exchange, structure, inner ear physiologogy
Abstract: Hereditary hearing impairment (HHI) is a heterogeneous class of disorders showing various patterns of inheritance and involving a multitude of different genes. Neurosensory hearing impairment is one of the most common human sensory disorders affecting one in 1000 children with at least 60% of cases being inherited. The mode of inheritance of non-syndromic hearing disorders can be assigned to autosomal dominant (10-15%), autosomal recessive (70%), X-linked (1-3%) and mitochondrial forms (6-37% out of all cases). Syndromal hearing defects are categorized according to the underlying defects and contain more than 700 syndromes. In daily practice, non-syndromic hearing impairment (NSHL) is predominant and accounts for up to 70% of all inherited sensorineural hearing defects. Although our knowledge of genes being involved in the development of HI accumulated during the past five years, little is known about the molecular basis of normal auditory function. To date, 24 genes for non syndromic HI and an even larger number of genes for syndromic HI have been identified. These genes play important roles for the normal inner ear: in the development, structure, ion exchange and further physiological function. This review presents a summary of known genes and new candidates, their possible role and the current state of knowledge in genetics of hereditary hearing impairment, all of them possibly expected to allow for new concepts in therapy.
Export Options
About this article
Cite this article as:
Haack B., Pfister M., Blin N. and Kupka S., Genes Involved in Hereditary Hearing Impairment, Current Genomics 2003; 4 (5) . https://dx.doi.org/10.2174/1389202033490321
DOI https://dx.doi.org/10.2174/1389202033490321 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondrial Complex I Deficiency in Humans
Current Genomics Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design Adult Stem Cells and Biocompatible Scaffolds as Smart Drug Delivery Tools for Cardiac Tissue Repair
Current Medicinal Chemistry The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Protein & Peptide Letters T Lymphocytes as Targets of Statins: Molecular Mechanisms and Therapeutic Perspectives
Inflammation & Allergy - Drug Targets (Discontinued) Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants
Current Cardiology Reviews Diabetes and Metallothionein
Mini-Reviews in Medicinal Chemistry Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry Repulsive Guidance Molecules (RGMs) and Their Potential Implication in Cancer as Co-receptor of BMPs
Current Signal Transduction Therapy Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design Mitochondrial Physiology and Toxicity (Mitotoxicity); Importance for the Immune System, Programmed Cell Death and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Current Cardiology Reviews Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy
Current Drug Targets Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) OX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Current Immunology Reviews (Discontinued) Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Current Cardiology Reviews microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design EDITORIAL [Hot Topic: Diabetes Cardiovascular Complications (Guest Editor: Costanza Emanueli)]
Endocrine, Metabolic & Immune Disorders - Drug Targets